Trial Profile
Clinical Research of Diquas ophthalmic solution 3% on corneal epithelial barrier function in dry eye
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2018
Price :
$35
*
At a glance
- Drugs Diquafosol (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Santen Pharmaceutical
- 21 Jun 2018 Status changed from recruiting to discontinued.
- 13 May 2016 New trial record